DBTX

Decibel Therapeutics, Inc. Common Stock

Delisted

DBTX was delisted on the 22nd of September, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$19M – – –
TGI
2
TRV GP III
Massachusetts
$12.1M – – –
BlackRock
3
BlackRock
New York
$6.97M +$19.6K +5,337 +0.3%
Alphabet Inc
4
Alphabet Inc
California
$6.3M – – –
SB
5
Samsara BioCapital
California
$3.09M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.47M – – –
Bessemer Group
7
Bessemer Group
New Jersey
$1.9M – – –
HMC
8
Harvard Management Company
Massachusetts
$1.25M -$10.2K -2,769 -0.8%
NM
9
Newtyn Management
New York
$770K -$197K -53,818 -21%
UOC
10
UBS O'Connor
Illinois
$767K +$36K +9,814 +5%
Millennium Management
11
Millennium Management
New York
$613K -$320K -87,093 -35%
BCM
12
Bronte Capital Management
Australia
$596K -$9.46K -2,577 -2%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$508K – – –
BCM
14
Bridgeway Capital Management
Texas
$459K – – –
JP Morgan Chase
15
JP Morgan Chase
New York
$450K -$31.9K -8,680 -7%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$445K – – –
Neuberger Berman Group
17
Neuberger Berman Group
New York
$226K +$158K +43,139 +275%
AI
18
Acuitas Investments
Washington
$162K +$154K +41,960 New
State Street
19
State Street
Massachusetts
$158K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$156K – – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$133K – – –
Renaissance Technologies
22
Renaissance Technologies
New York
$132K +$6.97K +1,900 +6%
ACA
23
Atlas Capital Advisors
Wyoming
$96.3K – – –
Federated Hermes
24
Federated Hermes
Pennsylvania
$77K – – –
Northern Trust
25
Northern Trust
Illinois
$73.5K – – –